Vimta Labs
| |
Vimta Labs | |
---|---|
Type | Public |
Industry | Biotechnology |
Founded | 1984 |
Slogan | Driven by Quality. Inspired by Science |
Headquarters | Plot Nos 141/2 & 142
IDA Phase II Cherlapally Hyderabad, 500 051 India |
Key people | Sivalinga Prasad - Vasireddi
Chairman Harita Vasireddi Managing Director M Murali Mohan Rao Chief Financial Officer Vasireddi Veerabhadra - Prasad Executive Director:Administration Vungal Harriman Executive Director:Operations A Venkata Ramana Secretary/Compliance Officer |
Number of employees | 501-1000 employees |
Contents
History
Vimta Labs is India´s leading contract research and testing organization. Established in 1984 VIMTA has an envious track record of serving several market leaders across the globe.
Vimta is a team of 984 professionals comprising 605 scientists in various disciplines such as Chemistry, Pharma, Medicine, Microbiology, Molecular biology and Informatics. The team is slated to double in next three years.
Vimta is a multi-site organization with more than 300,000 sqft world-class laboratory facilities.
Services
- Analytical
- Environmental Services
- Clinical Research
- Clinical Reference Lab Services
- Preclinical Division
- Bio-Pharma
- BA/BE studies
- Featured Departments
Top 5 Recent Tweets
Date | Author | Comment |
---|---|---|
May 18, 2022 | FintechStats | Conference Call transcript by Vimta Labs Ltd. Link: https://t.co/LICeTamWvB Date: 18-May-2022. Size: 22 pages. #FintechStats_VimtaLabs |
May 13, 2022 | AlphSt_India | Published on YouTube: Vimta Labs Ltd Q4 FY22 Earnings Concall https://t.co/hOC08dMm3s
|
May 13, 2022 | MarketsCafe | Vimta Labs Standalone March 2022 Net Sales at Rs 73.60 crore, up 23.71% Y-o-Y NULL #LatestNews by #MoneyControl https://t.co/yD5RzM5npC |
May 13, 2022 | equitybulls | Vimta Labs reports consolidated Q4 FY2022 net profit of Rs. 11.83 crores
|
May 13, 2022 | equitybulls | Vimta Labs Ltd recommends dividend of Rs. 2
|
Top 5 Recent News Headlines
Top 5 Lifetime Tweets
Top 5 Lifetime News Headlines
References
https://www.bloomberg.com/profiles/companies/VL:IN-vimta-labs-ltd